JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4976
PUT
Moderna
MRNA
$74.8B
| $266K | ﹤0.01% |
2,500
-9,600
| -79% | -$968K |
2020 Q1
16 quarters
|
|
4977
UroGen Pharma
URGN
$2.03B
| $265K | ﹤0.01% |
17,666
-6,278
| -26% | -$103K |
2019 Q2
19 quarters
|
|
4978
NI Holdings
NODK
$301M
| $265K | ﹤0.01% |
17,464
+6,726
| +63% | +$92.8K |
2017 Q4
25 quarters
|
|
4979
Custom Truck One Source
CTOS
$2.27B
| $264K | ﹤0.01% |
45,414
-31,523
| -41% | -$196K |
2020 Q2
15 quarters
|
|
|
SHCR
4980
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $264K | ﹤0.01% |
343,772
+66,334
| +24% | +$66.4K |
2021 Q3
10 quarters
|
|
4981
Lightspeed Commerce
LSPD
$1.31B
| $264K | ﹤0.01% |
18,758
-15,167
| -45% | -$241K |
2020 Q3
14 quarters
|
|
|
VTNR
4982
DELISTED
Vertex Energy, Inc
VTNR
| $263K | ﹤0.01% |
187,822
+140,789
| +299% | +$225K |
2022 Q2
7 quarters
|
|
4983
Viemed Healthcare
VMD
$355M
| $263K | ﹤0.01% |
27,879
+5,147
| +23% | +$44.1K |
2020 Q2
15 quarters
|
|
4984
CALL
Qiagen
QGEN
$9.43B
| $262K | ﹤0.01% |
5,931
-41,222
| -87% | -$1.88M |
2023 Q4
1 quarter
|
|
4985
Nomad Foods
NOMD
$1.53B
| $261K | ﹤0.01% |
13,356
+540
| +4% | +$9.95K |
2017 Q2
27 quarters
|
|
4986
Schwab 1000 Index ETF
SCHK
$5.85B
| $261K | ﹤0.01% |
10,286
+256
| +3% | +$6.16K |
2022 Q3
6 quarters
|
|
|
DM
4987
DELISTED
Desktop Metal, Inc.
DM
| $260K | ﹤0.01% |
29,582
+9,440
| +47% | +$60.6K |
2020 Q3
14 quarters
|
|
4988
Olema Pharmaceuticals
OLMA
$693M
| $259K | ﹤0.01% |
22,885
-5,691
| -20% | -$73.4K |
2020 Q4
13 quarters
|
|
4989
ProShares K-1 Free Crude Oil Strategy ETF
OILK
$226M
| $259K | ﹤0.01% |
5,418
-18,498
| -77% | -$826K |
2022 Q3
6 quarters
|
|
|
PVBC
4990
DELISTED
Provident Bancorp
PVBC
| $259K | ﹤0.01% |
28,412
+13,786
| +94% | +$138K |
2017 Q4
25 quarters
|
|
4991
Rush Street Interactive
RSI
$2.38B
| $258K | ﹤0.01% |
39,704
-81,414
| -67% | -$438K |
2021 Q2
11 quarters
|
|
4992
DocGo
DCGO
$35.8M
| $258K | ﹤0.01% |
63,754
-46,747
| -42% | -$176K |
2022 Q2
7 quarters
|
|
4993
PGIM Short Duration Multi-Sector Bond ETF
PSDM
$246M
| $257K | ﹤0.01% |
+5,078
| New | +$257K |
2024 Q1
0 quarters
|
|
|
PAMT
4994
PAMT Corp
PAMT
$242M
| $257K | ﹤0.01% |
15,878
+4,999
| +46% | +$93.6K |
2016 Q4
29 quarters
|
|
4995
Fidelity Small-Mid Multifactor ETF
FSMD
$2.55B
| $257K | ﹤0.01% |
6,620
+196
| +3% | +$7.2K |
2023 Q2
3 quarters
|
|
4996
Flexsteel Industries
FLXS
$359M
| $257K | ﹤0.01% |
6,885
+6,777
| +6,275% | +$207K |
2023 Q3
2 quarters
|
|
4997
iShares Currency Hedged MSCI Emerging Markets
HEEM
$303M
| $257K | ﹤0.01% |
10,000
-486
| -5% | -$12K |
2023 Q4
1 quarter
|
|
|
CLBTW
4998
DELISTED
Cellebrite DI Ltd. Warrants
CLBTW
| $256K | ﹤0.01% |
+10,000
| New | +$19.8K |
2023 Q2
3 quarters
|
|
4999
Roadzen
RDZN
$104M
| $256K | ﹤0.01% |
39,435
+28,727
| +268% | +$170K |
2023 Q4
1 quarter
|
|
5000
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
$3.25B
| $256K | ﹤0.01% |
4,771
+112
| +2% | +$5.8K |
2023 Q4
1 quarter
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.